Jennifer Bragg and Bill McConagha have joined Latham & Watkins as partners with the firm’s healthcare practice in Washington, the firm said Monday.
Bragg counsels companies on compliance and investigations stemming from enforcement actions initiated by the Food and Drug Administration and other governmental authorities, including the Justice Department of Justice. She also advises pharma, medical device, and other FDA-regulated companies on complex transactional matters, according to Latham.
McConagha advises companies on the lifecycle of FDA-regulated products, ranging from drugs to medical devices, to complex biologics, food products, and novel tobacco products. He counsels clients on pre-market development and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.